USPTO 2015–2025 USPTO PatentsView US Corporation

Gauthier Biomedical, Inc

USPTO PatentsView assignee record — 50 granted patents across 14 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B25G (HANDLES FOR HAND IMPLEMENTS).

50
Total patents granted
14
CPC technology areas
5.5
Avg claims per patent
+8%
5-year filing velocity

Portfolio overview

Gauthier Biomedical, Inc has been granted 50 US utility patents between 2015 and 2025, placing Gauthier Biomedical, Inc at rank #6,657 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 5.5 claims per patent with primary concentration in B25G (HANDLES FOR HAND IMPLEMENTS). As a US Corporation, Gauthier Biomedical, Inc is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 34.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 26 grants, compared with 24 in the 2015–2019 window — a +8% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Gauthier Biomedical, Inc's 5.5 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 14 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Gauthier Biomedical, Inc against peers pursuing similar technology classes.

How does Gauthier compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Gauthier holds 50 patents — placing it at rank #6,657 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

024681012 20152016201720182019202020212022202320242025 2
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Gauthier Biomedical, Inc patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 8.0%
2016 3 6.0%
2017 10 20.0%
2018 2 4.0%
2019 5 10.0%
2020 8 16.0%
2021 4 8.0%
2022 5 10.0%
2023 6 12.0%
2024 1 2.0%
2025 2 4.0%

Which technologies does Gauthier Biomedical, Inc patent most?

Top 14 of 14 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Simple
Velocity Growing

Where it ranks

Overall rank by patents

#6,657

Across all tracked assignees

Innovation Score

34.8 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Gauthier Biomedical, Inc hold?
Gauthier Biomedical, Inc holds 50 US granted patents filed between 2015 and 2025, spanning 14 technology areas.
What is Gauthier Biomedical, Inc's Innovation Score?
Gauthier Biomedical, Inc has an Innovation Score of 34.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Gauthier Biomedical, Inc focus on?
Gauthier Biomedical, Inc's top technology area is B25G (HANDLES FOR HAND IMPLEMENTS) with 13 patents. The company has filed patents in 14 CPC subclasses total.
Is Gauthier Biomedical, Inc's patent filing rate increasing or decreasing?
Gauthier Biomedical, Inc's recent filing velocity is +8% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Gauthier Biomedical, Inc's patents?
Gauthier Biomedical, Inc's patents average 5.5 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Gauthier Biomedical, Inc patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope